© 2004 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Gap junction-mediated spread of cell injury and death during myocardial ischemia–reperfusion
Laboratorio de Cardiología Experimental, Servicio de Cardiología, Hospital Universitario Valle de Hebron, Barcelona, Spain
* Corresponding author. Laboratorio de Investigación Cardiovascular, Hospitals Vall d'Hebron, Pg. Vall d'Hebron 119–129, 08035 Barcelona, Spain. Tel.: +34-93-4894038; fax: +34-93-4894032. dgdorado{at}vhebron.net
Gap junction-mediated intercellular communication (GJMIC) has been known for a long time to be essential in propagation of electrical impulse in the heart, and the contribution of altered GJMIC to the genesis of arrhythmias has been extensively investigated. However, although it is well known that GJMIC allows the exchange of biologically important molecules between adjacent cells, the pathophysiological significance of such chemical coupling during myocardial ischemia and reperfusion is much less known. It has been solidly established that ischemia impairs GJMIC and eventually leads to electrical uncoupling, but recent studies suggest that GJMIC may still allow synchronization of the onset of ischemic rigor contracture and of the progression of ischemic injury beyond rigor onset. During reperfusion, GJMIC has been shown to mediate cell-to-cell propagation of hypercontracture and cell death, and there is evidence that this phenomenon explains the continuity of areas of contraction band necrosis and contributes to final infarct size. Finally, there is increasing evidence that GJ or their protein components are involved in the genesis of the protective effect of ischemic preconditioning, although probably through mechanisms independent from modulator of GJMIC. GJ play an important role in the pathphysiology of cell injury and death during myocardial ischemia–reperfusion and are potential targets for new cardioprotective therapeutic strategies.
KEYWORDS Myocardial infarction; Ischemic heart disease; Cardiomyocytes
Time for primary review 9 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Wang and Y. Cheng The tail of Cx43: its crucial protective role in acute myocardial infarction Cardiovasc Res, October 22, 2009; (2009) cvp329v2. [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Hennan, R. E. Swillo, G. A. Morgan, E. I. Rossman, J. Kantrowitz, J. Butera, J. S. Petersen, S. J. Gardell, and G. P. Vlasuk GAP-134 ([2S,4R]-1-[2-Aminoacetyl]4-Benzamidopyrrolidine-2-Carboxylic Acid) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 207 - 214. [Abstract] [PDF]
|
|
|
|
|
|
W. Srisakuldee, M. M. Jeyaraman, B. E. Nickel, S. Tanguy, Z.-S. Jiang, and E. Kardami Phosphorylation of connexin-43 at serine 262 promotes a cardiac injury-resistant state Cardiovasc Res, September 1, 2009; 83(4): 672 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Miro-Casas, M. Ruiz-Meana, E. Agullo, S. Stahlhofen, A. Rodriguez-Sinovas, A. Cabestrero, I. Jorge, I. Torre, J. Vazquez, K. Boengler, et al. Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake Cardiovasc Res, September 1, 2009; 83(4): 747 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Severs, A. F. Bruce, E. Dupont, and S. Rothery Remodelling of gap junctions and connexin expression in diseased myocardium Cardiovasc Res, October 1, 2008; 80(1): 9 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H.-C. Lin, N. Lou, N. Kang, T. Takano, F. Hu, X. Han, Q. Xu, D. Lovatt, A. Torres, K. Willecke, et al. A Central Role of Connexin 43 in Hypoxic Preconditioning J. Neurosci., January 16, 2008; 28(3): 681 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruiz-Meana, A. Rodriguez-Sinovas, A. Cabestrero, K. Boengler, G. Heusch, and D. Garcia-Dorado Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury Cardiovasc Res, January 15, 2008; 77(2): 325 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Lascano and J. A. Negroni Gap junctions in preconditioning against arrhythmias Cardiovasc Res, June 1, 2007; 74(3): 341 - 342. [Full Text] [PDF]
|
|
|
|
|
|
D. Garcia-Dorado, A. Rodriguez-Sinovas, M. Ruiz-Meana, J. Inserte, L. Agullo, and A. Cabestrero The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion Cardiovasc Res, May 1, 2006; 70(2): 274 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Camelliti, T. K. Borg, and P. Kohl Structural and functional characterisation of cardiac fibroblasts Cardiovasc Res, January 1, 2005; 65(1): 40 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium J. Physiol., August 15, 2004; 559(1): 245 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Camelliti, G. P Devlin, K. G Matthews, P. Kohl, and C. R Green Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction Cardiovasc Res, May 1, 2004; 62(2): 415 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Garcia-Dorado Myocardial reperfusion injury: a new view Cardiovasc Res, February 15, 2004; 61(3): 363 - 364. [Full Text] [PDF]
|
|